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INTRODUCTION
bcl-2 is unique amongst proto-oncogenes in that it functions as
a repressor of programmed cell death (for review, see
Korsmeyer, 1992). The bcl-2 gene was isolated from the break-
point of the t(14;18) chromosomal translocation found in fol-
licular lymphoma (Tsujimoto et al., 1985; Bakhshi et al., 1985;
Cleary and Sklar, 1985). The juxtaposition of bcl-2 with the
immunoglobulin (Ig) heavy chain locus results in a marked
deregulation and overexpression of bcl-2 RNA and protein
(Graninger et al., 1987; Seto et al., 1988). Transgenic mice that
bear a bcl-2-Ig minigene that recapitulates this translocation
demonstrated extended B cell survival and an expansion of
resting B cells (McDonnell et al., 1989). Other transgenic mice,
which redirected bcl-2 to immature thymocytes, expanded the
role of bcl-2 as an antidote to apoptosis (Sentman et al., 1991;
Strasser et al., 1991). bcl-2 conferred resistance to glucocor-
ticoids, radiation and T cell receptor-induced cell death, while
it did not prevent negative selection events. Overexpression of
bcl-2 in certain hematopoietic cell lines has been shown to
inhibit programmed cell death following cytokine deprivation
(Vaux et al., 1988; Hockenbery et al., 1990; Nunez et al.,
1990). Recently, bcl-2 has also been shown to protect primary
neuronal cell cultures (Allsopp et al., 1993; Garcia et al., 1992)
as well as PC12 cells (Batistatou et al., 1993; Mah et al., 1993)
from neurotrophic factor withdrawal-induced cell death. The
mechanism by which bcl-2 delays or prevents the onset of pro-
grammed cell death is unknown. bcl-2 protein is an integral
membrane protein that has been localized to mitochondria
(Hockenbery et al., 1990) as well as other membranes (Chen-
Levy et al., 1989; Alnemri et al., 1992; Jacobson et al., 1993).
A role for bcl-2 in regulating the naturally occurring cell
death that takes place in tissues of virtually all organisms is
suggested by the topographic distribution of bcl-2 protein
(Hockenbery et al., 1991). Adult tissues that express bcl-2 are
characterized by (1) renewing stem cell populations, such as
those found in hematopoietic lineages and complex differenti-
ating epithelium, (2) glandular epithelium and (3) long-lived
postmitotic cell populations. 
A hallmark of nervous system development is the extensive
histogenetic cell death that takes place relatively late in matu-
ration and results in the loss of 20-80% of all neurons.
According to the neurotrophic theory of neuronal cell death
(reviewed in Oppenheim, 1991), differentiated, postmitotic
neurons that fail to compete successfully for target-derived
neurotrophic factors die. Other factors that may influence this
developmental cell death include electrical activity (Lipton,
1986), afferent stimulation (reviewed by Oppenheim, 1991)
and local factors such as cell-cell and cell-matrix interactions
(Walicke, 1989). 
Given the evidence that bcl-2 is involved in controlling pro-
grammed cell death in several in vitro and in vivo systems, we
have examined the involvement of bcl-2 in nervous system
development. First, we investigated the expression of bcl-2
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Cell death is a common feature of neural development in
all vertebrates. The bcl-2 proto-oncogene has been shown
to protect a variety of cell types from programmed cell
death. We have examined the distribution of bcl-2 protein
in the developing and adult nervous systems. bcl-2 protein
is widespread during embryonic development. Proliferat-
ing neuroepithelial cells of ventricular zones as well as the
postmitotic cells of the cortical plate, cerebellum, hip-
pocampus and spinal cord express bcl-2. Postnatally, bcl-2
is principally retained in the granule cells of the cerebel-
lum and dentate gyrus of the hippocampus. bcl-2
expression in the CNS declines with aging. In the periph-
eral nervous system, neurons and supporting cells of sym-
pathetic and sensory ganglia retain substantial bcl-2
protein throughout life. The widespread expression of bcl-
2 in CNS and PNS neurons during embryonic development
and its selective retention in the adult PNS is consistent
with a role for bcl-2 in regulating neuronal survival. In
addition, the expression of bcl-2 in some neuronal popula-
tions beyond the recognized period of cell death is sugges-
tive of a role for bcl-2 beyond simply protecting neurons
from developmental cell death.
Key words: bcl-2 protein, expression, nervous system, cell death,
human, monkey
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protein in the developing mouse brain. Next, we examined bcl-
2 expression in the adult brain in order to identify the cell types
retaining bcl-2 expression. Finally, we analyzed bcl-2
expression in the peripheral nervous system, which unlike the
central nervous system, displays the capacity in the adult to
regenerate following injury.
MATERIALS AND METHODS 
Two Rhesus monkey brains (16 and 18 years old) were obtained at
autopsy (from naturally expired animals kept at the Bethesda Eye
Institute, St Louis, MO). Human frontal cortex was obtained from
surgical biopsy material from a 6-year-old girl. Tissue was snap-
frozen in OCT without prior fixation. Frozen sections (5 µm) were
fixed in methanol at −20°C for 2 minutes, rinsed in PBS (for mouse
staining) or 0.5 M Tris-HCl (for monkey and human staining),
blocked with avidin and biotin (Vector Laboratories) for 10 minutes
each, blocked with PBS containing 1% bovine serum albumin, 0.2%
dry milk, and 0.3% Triton X-100 (for mouse staining) or 0.5 M Tris-
HCl containing 1% fetal bovine serum (for monkey and human
staining) for 15 minutes, and incubated with the primary antibody
overnight at 4°C. A hamster anti-human bcl-2 monoclonal antibody,
6C8 (Hockenbery et al., 1990), was used on monkey and human
sections at a concentration of 50 µg/ml; mouse sections were stained
with one of three anti-bcl-2 antibodies: (1) monoclonal hamster anti-
mouse bcl-2 antibody 3F11 (used at 15 µg/ml), (2) monoclonal rat
anti-mouse bcl-2 antibody 4C11 (used at 100 µg/ml)(a gift from Dr
Gabriel Nunez, Ann Arbor), or (3) polyclonal rabbit anti-mouse bcl-
2 antibody B1 (used at 80 µg/ml)(a gift from Dr Gabriel Nunez,
Protein A purified). Monoclonal antibody 3F11 was produced in an
Armenian hamster using recombinant full-length mouse bcl-2 (Veis
et al., 1993). Monoclonal rat and polyclonal rabbit anti-mouse bcl-2
antibodies were made by injecting animals with recombinant mouse
bcl-2 fusion protein (mouse bcl-2 containing a C-terminal 22 amino
acid deletion fused to glutathione-S-transferase; GST gene fusion
system, Pharmacia). Negative control antibody was a monoclonal
hamster anti-human tumor necrosis factor antibody (TN3)(a gift from
Dr Robert Schreiber, St Louis, MO) for the hamster monoclonals,
preimmune serum (also Protein A purified) for the rabbit antibody
and blocking buffer alone for the rat monoclonal antibody. Following
primary antibody incubation, slides were incubated with either a
biotinylated goat anti-hamster IgG, biotinylated goat anti-rat IgG, or
biotinylated goat anti-rabbit IgG (CalTag, Inc.) for 30 minutes at
room temperature, followed by an incubation with biotinylated swine
anti-goat IgG (CalTag, Inc.) All secondary and tertiary antibodies
were absorbed against murine antigens by the manufacturer or by us,
using mouse liver acetone powder. Sections were quenched for
endogenous peroxidase activity by treating with 0.18% hydrogen
peroxide in methanol for 15 minutes at room temperature, then
incubated with horseradish peroxidase-conjugated streptavidin
(Zymed, Inc.) for 30 minutes before developing with diaminobenzi-
dine (BioRad, Inc.). Sections were counter-stained with alcian
blue/methyl green. Analysis was performed on a Zeiss or Nikon pho-
tomicroscope. For double-staining experiments, monoclonal mouse
a n t i - n e u r o filament and anti-glial fibrillary acidic protein antibodies
were generated by one of us (W. H.), and anti-CD45 monoclonal
antibody T29/33 (Omary et al., 1980) was obtained from Dr Matthew
Thomas (Washington University, St Louis). The monoclonal
antibody 2H3 (against the 155×1 03 Mr n e u r o filament protein) was
obtained from the Developmental Studies Hybridoma Bank, National
Institute of Child Health and Development, and has been described
(Dodd et al., 1988; Chisaka et al., 1992). For these experiments,
primary antibodies and secondary detection systems were incubated
with sections either simultaneously or sequentially. Secondary anti-
bodies were absorbed with liver acetone powder to prevent cross-
reactivity with the inappropriate primary antibodies and with each
other. Cross-reactivity experiments were performed to ensure the
absence of cross-reactivity. In addition, primary antibodies were
incubated with sections alone, as well as in combination. FITC-con-
jugated streptavidin (Sigma) was used following the tertiary antibody
incubation, and a Texas Red-conjugated horse anti-mouse IgG was
used for cell-type-specific antibodies. Western blotting was
performed as previously described (McDonnell et al., 1990). After
incubation with streptavidin-peroxidase conjugate (Zymed), devel-
opment was with diaminobenzidine, enhanced with 0.03% nickel
chloride (B1), or with enhanced chemiluminescence (ECL,
Amersham) (3F11, 4C11). 
RESULTS
bcl-2 expression in the central nervous system
Developmental expression
During embryonic and early postnatal development, bcl-2
protein can be detected in two different populations of cells:
neuroepithelial cells of ventricular zones and postmitotic cells
of several defined regions, including the cortical plate, devel-
oping cerebellum, hippocampus and spinal cord.
Ventricular zone and cortical plate
At E10.5 in the mouse, the nervous system consists entirely of
proliferating neuroepithelial cells. bcl-2 expression appears
uniform in these cells throughout the CNS, except in the
mitotic zone (Bayer and Altman, 1991) immediately adjacent
to the ventricles where a large number of unstained cells can
be seen (Fig. 1A; also E12.5, Fig. 1B). A proliferating popu-
lation of neuroblasts (the ventricular zone) surrounding the
ventricles is maintained as the brain develops. bcl-2 is
expressed in the ventricular zone until this layer disappears
around the time of birth (Fig. 1B-D); however, expression in
the subventricular zone, an additional proliferative zone, can
still be seen at postnatal day 11 (P11) (not shown). 
At about E14 in the mouse, cells begin to differentiate and
migrate out of the ventricular zone to form the cortical plate.
The cortical plate is a densely packed zone of postmitotic cells,
which are beginning to send out processes and form synaptic
connections; it is most prominent around E16.5. bcl-2
expression appears uniformly high in this region (Fig. 1C). In
whole embryo sections, the levels of bcl-2 expression in this
layer are consistently higher than any other site in the body
(Veis et al., unpublished data). At high power, bcl-2 staining
is very intense and covers the entire cell, including the nucleus.
Cells in the process of migrating from the ventricular zone to
the cortical plate comprise the intermediate zone; bcl-2
expression is low or absent in these migrating cells (Fig. 1C,D).
From E14.5 to E16.5, cells in the ventricular zone contain more
bcl-2 than those in the adjacent intermediate zone, but less than
those in the cortical plate. By E18.5, many cells within the
cortical plate have differentiated to form the cortical layers
found in the adult. bcl-2 staining in the cortical plate is less
intense and less homogeneous at this time (Fig. 1D). At P3,
many cells in the cortical gray still express bcl-2, although the
staining has decreased further on a cell-to-cell basis, as shown
in Fig. 1E. Interestingly, subplate neurons, seen in Fig. 1C-E,
express high levels of bcl-2 throughout this time. By P11, a
further decrease in bcl-2 staining in the cortical gray is noted
(data not shown). 
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Cerebellar cortex
A dynamic pattern of bcl-2 expression is observed in the
developing cerebellar cortex. During the development of the
cerebellar cortex (E14-E15), neurons arise from two different
ventricular zones, Purkinje cells from the ventricular
germinal zone in the fourth ventricle and cerebellar local-
circuit neurons (granule cells, stellate cells, and basket cells)
from the external germinal layer (EGL), a layer of cells
covering the surface of the cerebellum that originates from
cells of the fourth ventricle. The EGL starts as a single cell
layer and proliferates to form a layer six to eight cells deep.
Two subpopulations of cells exist within the EGL (Ramon y
Cajal, 1911), an external cycling population (EGLa), and an
internal differentiating layer (EGLb) (Altman, 1972; Kuhar et
al., 1993). Up to 3% of postmitotic neurons in the EGL die
before P21 in the developing mouse cerebellum (Jacobson,
1991). 
At E18.5 (Fig. 2A), bcl-2 is expressed in the cerebellar
mantle layer, composed of developing Purkinje and glial cells,
and in the deeper cells of the cerebellum. Strikingly, there is
little or no bcl-2 expression in the developing external germinal
layer. By P11, however, significant bcl-2 expression can be
detected in the external germinal layer (Fig. 2B). Upon closer
inspection, bcl-2 appears to be somewhat increased within the
inner differentiating zone of the external germinal layer, EGLb
(seen best with antibody B1, Fig. 2F, but also seen repro-
ducibly with 3F11). Cells within the developing internal
granule cell layer clearly contain immunoreactive bcl-2
protein. At this time, the single row of Purkinje cells varies in
its positivity for bcl-2. Differences in Purkinje cell staining
with 3F11 and B1 probably relate to differences in epitope pre-
sentation with the fixation/staining protocol used here. Con-
siderable expression of bcl-2 is seen in the mouse cerebellum
throughout the first postnatal month (data not shown), beyond
the time when cell death occurs within the EGL. However, by
5 months of age, the amount of immunoreactive bcl-2 is sub-
stantially decreased (Fig. 2D).
Hippocampus
The developing hippocampus also expresses bcl-2 (Fig. 3).
This expression is widespread throughout the dentate gyrus and
subiculum from E18.5 through P11 (Fig. 3A-D), but decreases
substantially by P28 (Fig. 3E). Neuron production in most hip-
pocampal regions is completed before birth in the mouse;
however, in the dentate gyrus, neurons continue to be formed
until P20 (Angevine, 1965; Bayer et al., 1980). Cell death
within the differentiated neurons of the dentate gyrus is thought
to occur between P20 and P27 (Wimer et al., 1988). Both the
monoclonal antibody 3F11 and the polyclonal antibody B1
stain the inner cells of the dentate gyrus more intensely than
the more differentiated outer cells (Fig. 3A,B). These inner
cells of the developing dentate gyrus comprise a stem cell pop-
ulation that arises from cells of the lateral ventricle that migrate
along the hippocampal fimbria to the inner region of the
dentate gyrus. 
The expression of bcl-2 in the hippocampus has diminished
considerably by 5 months of age in the mouse, with only occa-
sional cells of the dentate gyrus staining with the antibody
3F11 (Fig. 3F). Given that neurogenesis may continue in the
adult dentate gyrus (Kaplan and Hinds, 1977), these cells may
represent a functionally distinct subset.
Confirmation of the immunohistochemical data in cerebel-
lum and hippocampus was obtained by Western analysis of
protein lysates from P10 cerebellum and hippocampus using
3F11 and 4C11 monoclonal and B1 polyclonal antibodies (Fig.
4). 
Spinal cord
Considerable cell death (as much as 60-70%) takes place
during the development of spinal motoneurons (Lance-Jones,
1982; Oppenheim, 1986; Oppenheim et al., 1986). In addition,
cell counting studies in the mouse (Lance-Jones, 1982) indicate
that cell deaths in the alpha motoneurons of the lateral motor
column occur between E13 and E18. Essentially no cell death
within this neuron population takes place after birth (Lance-
Fig. 1. bcl-2 expression in the developing cortex. (A) E10.5 mouse forebrain stained with 3F11. (B) E12.5 mouse brain surrounding lateral
ventricle stained with 3F11. The surface of the head is at the top, with thalamus at the lower left. (C) E16.5 mouse brain oriented as in B,
stained with 3F11. Apparent staining of the choroid plexus is an artifact. Note that cells within the thalamus do not stain for bcl-2 (as in B).
(D) E18.5 brain superficial to the lateral ventricle. (E) Cortical gray at P3 stained with 3F11. Surface of the brain is at the top. Scale bar, 100
µm.
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Jones, 1982; Oppenheim, 1986). For these reasons, we inves-
tigated the pattern of bcl-2 expression in the developing mouse
spinal cord from days E13.5 through E18.5. In the lumbar
spinal cord at E13.5 (Fig. 5A,D), bcl-2 expression is greater
within the differentiating neurons of the mantle layer than in
the proliferating neuroblasts surrounding the neural canal. The
motoneurons of the developing lateral motor column express
even more bcl-2 than surrounding cells. At E16.5 (Fig. 5B,E),
bcl-2 expression is seen in many cells throughout the mantle
zone of the spinal cord; this staining is fairly heterogeneous.
As seen at E13.5, bcl-2 expression is higher within the alpha
motoneurons of the developing lateral motor column than in
surrounding cells. The requirement for the use of frozen
sections in these experiments prevents the identification of
dying neurons. Therefore, we were unable to assess the
expression of bcl-2 in those neurons undergoing programmed
cell death. At embryonic day 18.5 (Fig. 5C,F), bcl-2 expression
within the lumbar spinal cord is substantially the same as that
seen at E16.5, with heterogeneous staining throughout the
mantle layer. Again, somewhat higher bcl-2 expression can be
seen in the motoneurons of the lateral motor column. These
data show continued expression of bcl-2 in the alpha motoneu-
rons of the lateral motor column seen in lumbar (Fig. 5) and
cervical (not shown) spinal cord before, during and after the
period during which the majority of these neurons die. While
we cannot address the expression of bcl-2 in dying neurons of
this population, we can say that it is retained in cells that
survive. Postnatal expression of bcl-2 in the spinal cord is sub-
stantially decreased. By two months, there is considerably less
bcl-2 protein overall; nonetheless, many cells in the dorsal,
medial and ventral aspects of the cervical spinal cord still
express bcl-2 (Fig. 4G-I). At 5 months, even fewer neurons
express bcl-2 (not shown). Motor neurons of the adult spinal
cord, in addition to neurons of the PNS (discussed below) are
capable of regenerating their axons following injury. The
continued expression of bcl-2 in some large ventral horn
neurons may relate to this capacity. 
Olfactory bulb and nasal epithelium
As with the cerebellum and hippocampus, the olfactory bulb
represents a neuronal population that undergoes postnatal neu-
rogenesis, particularly of granule cells (Jacobson, 1991). At
P11 in the mouse, bcl-2 expression can be seen in mitral cells
and granule cells (the first- and second-order neurons, respec-
D. E. Merry and others
Fig. 2. bcl-2 expression in mouse cerebellum. (A) E18.5 cerebellum, stained with 3F11. The external germinal layer is relatively negative,
while the mantle zone, composed of differentiating Purkinje cells, glial cells, and some granule cells is positive. Scale bar, 50 µm. (B) P11
cerebellar cortex, stained with 3F11. (C) Adjacent P11 section stained with control TNF antibody. (D) 5 month cerebellar cortex, stained with
3F11. Scale bar, 100 µm. (E) Higher magnification of B. (F) P11 cerebellar cortex, stained with the polyclonal antibody B1. Egla designates the
outer proliferating zone of the external germinal layer; Eglb designates the inner early differentiating cells of the external germinal layer. Note
the increased bcl-2 staining in the Eglb compared to Egla. Scale bar, 25 µm. 
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tively, of the olfactory bulb), as well as within the glomeruli
(which contain synapses from olfactory neurons on mitral cell
dendrites) of the main olfactory bulb (Fig. 6A). In addition,
bcl-2 protein is apparent within the cells of the accessory
olfactory bulb (AOB) at this time (not shown). Neurogenesis
is thought to continue in the olfactory bulb in the adult (Kaplan
and Hinds, 1977; Bayer, 1983). At 5 months (Fig. 6B), sub-
stantial bcl-2 expression can be detected in the mitral cells (the
first-order neurons of the olfactory bulb) as well as in the
glomeruli (not shown). Granule cell expression appears to be
decreased relative to P11. Expression within the accessory
olfactory bulb also remains high (Fig. 6C), specifically within
the glomeruli and the stellate cells (the first-order neurons of
the AOB). 
The olfactory epithelium represents a unique neuronal pop-
ulation that continues neurogenesis in the adult. It is similar to
the epidermis in many aspects of its differentiation (Mahan-
thappa and Schwarting, 1993). Given the continued neurogen-
esis in this structure, along with the finding of bcl-2 expression
in olfactory bulb glomeruli in the adult (Fig. 6C), we examined
adult olfactory epithelium for bcl-2 expression. As shown in
Fig. 6D, bcl-2 protein can be seen in differentiating neurons of
the olfactory epithelium. Substantially less immunoreactive
bcl-2 can be seen in stem cells (arrowhead) than in the differ-
entiating neurons above. bcl-2 can also be seen in the Schwann
cells surrounding the axon bundles located below the epithe-
lial layer.
Adult expression patterns
By 5 months of age in the mouse, the amount of neuron-
specific bcl-2 expression has substantially decreased. Cerebel-
lar granule cells and granule cells of the dentate gyrus express
little or no bcl-2 at 5 months (compare P11 to 5 months in Figs
2B versus D, 3C versus F), and spinal cord neurons express
substantially less bcl-2 than at birth (compare E18 to 2 months,
Fig. 5C,F versus G,I).
To further address bcl-2 expression in the adult, we analyzed
16- and 18-year-old Rhesus monkey brains using the anti-
human bcl-2 antibody, 6C8. The following regions were
analyzed: pituitary, medulla, pons, substantia nigra, cerebellar
cortex, visual cortex, parietal cortex, frontal cortex, temporal
cortex, anterior and posterior thalamus, hypothalamus, hip-
pocampus, globus pallidus, caudate and putamen. A survey of
the monkey brain in this fashion showed that the vast majority
of bcl-2 protein in the adult brain resulted from microglial
expression. In addition, immunostaining of human frontal
cortex obtained at surgical biopsy revealed identical findings.
Fig. 7 shows the results of immunohistochemistry experiments
using 6C8 alone and in combination with two cell type-specific
antibodies. The microglial pattern of expression is documented
in Fig. 7A and C. Two-color immunofluorescence (Fig. 7C-F)
revealed that virtually all of the bcl-2-positive cells in human
frontal cortex also co-express the microglial marker CD45.
Within the central nervous system, CD45 expression is seen in
microglia, macrophages found in meninges and around blood
vessels, and in rare lymphocytes (Lassman et al., 1991). In this
Fig. 3. bcl-2 expression in the hippocampus. Dentate gyrus of a P11
mouse stained with 3F11 (A), and the polyclonal antibody B1 (B).
Note that the staining appears to be greater within the innermost cells
of the dentate gyrus (B), which at this time represent a stem cell
population. Higher magnification of the dentate gyrus is seen in (C)
at E18.5, (D) at P11, (E) at P28, and (F) at 5 months. Staining in C-F
is with 3F11. Scale bar in A, B and F, 100 µm. Scale bar in C, D and
E, 50 µm.
Fig. 4. Western blots of P10
hippocampus (h), cerebellum (c)
and thymus (t), adult cerebellum
(Ac) and a pro-B cell line
FL5.12 (B) reacted with 3F11
(top), B1 (middle), and 4C11
(bottom). The 25×103 Mr bcl-2
protein is the only protein
specifically detected by all
antibodies.
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context, microglial cells are substantially more abundant than
other CD45-expressing cells. Similar two-color immunofluo-
rescence experiments using anti-glial fibrillary acidic protein
antibody and 6C8 showed no bcl-2-positive astrocytes (not
shown). The only cells of the adult monkey brain consistently
exhibiting a non-microglial pattern of expression were the neu-
roendocrine cells of the anterior pituitary (Fig. 7B). However,
while the majority of neurons did not express bcl-2 (Fig. 7E,F),
rare, individual neurons exhibited both the 200×103 Mr neuro-
filament protein and bcl-2 (Fig. 7G,H). The functional differ-
ence between these and other neurons is unknown.
bcl-2 expression in the peripheral nervous system
The peripheral nervous system differs from the central nervous
system in several ways, including its neural crest origin and its
regenerative capacity following injury (reviewed by Johnson
et al., 1986). We investigated expression of bcl-2 in three struc-
tures of the peripheral nervous system: the superior cervical
ganglion, dorsal root ganglion and the adrenal gland. 
Superior cervical ganglion
Expression of bcl-2 in neurons of the superior cervical
ganglion is shown in Fig. 8. At P20 (Fig. 8A), substantial
expression of bcl-2 can be seen in these postmitotic sympa-
thetic neurons. In contrast to the temporal pattern of bcl-2 seen
in the central nervous system, these sympathetic neurons
remain strongly positive at 2.5 months (Fig. 8B) and 5 months
(data not shown). Of note, a varied intensity of bcl-2 is
observed in different sympathetic neurons. 
Dorsal root ganglion
Fig. 9 shows the expression of bcl-2 in the mouse dorsal root
ganglion (DRG) at E18.5, P20 and 5 months of age (Fig. 9A,C
and E, respectively). It is evident from this figure that bcl-2
expression in these neurons remains high throughout life. Con-
sistent with this finding, expression of bcl-2 in the DRG of an
18-year-old Rhesus monkey can also be seen (Fig. 9G). In
addition, during normal development, about half of the DRG
neurons that are produced will die (reviewed by Jacobson,
Fig. 6. bcl-2 staining in the olfactory bulb (A-C) and olfactory epithelium (D). (A) Horizontal section of P11 olfactory bulb stained with 3F11.
Both mitral (arrowhead) and granule (arrow) neurons are positive at this time. (B) Horizontal section of 5 month olfactory bulb. The first-order
mitral cells (arrowhead) are positive, while the granule cells (arrow) show reduced expression. (C) Accessory olfactory bulb. The stellate
neurons (open arrowhead), the first-order neurons in this structure, are positive, as are glomeruli (open arrow), which contain synapses from
olfactory neurons. Glomeruli of the main olfactory bulb are also positive (not shown). (D) Adult olfactory epithelium stained with 3F11. Note
that the basal cells (arrowhead) are negative, while the differentiating neurons located above the basal cells are positive. The sustentacular cells
(arrow), located next to the outermost ciliated bulbs (which contain the dendrites of the most mature neurons) appear less intense than the
neurons. Scale bar in A and C, 50 µm. Scale bar in B and D: for B, 25 µm; for D, 12.5 µm.
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1991). This process is known to be affected
by the supply of target-derived neu-
rotrophic factors, but may be influenced by
other factors as well, since many neurons
die before reaching their targets. bcl-2 is
expressed in these neurons throughout the
period of cell death (Fig. 5). 
In addition to the typical cytoplasmic
distribution of bcl-2 seen in most DRG
neurons, a nuclear staining pattern is also
seen with the 3F11 antibody. This nuclear
staining pattern has been noted in develop-
ing neurons throughout the brain, as well as
in some other organs using 3F11 (Veis et
al., 1993). However, the staining pattern
seen with 3F11 can appear strictly cyto-
plasmic within certain cell types (eg.
medullary thymocytes). Immunostaining of
mouse DRG with another monoclonal
antibody, 4C11, is shown in Fig. 9F; here
the staining is primarily cytoplasmic, con-
sistent with the pattern seen with the anti-
human bcl-2 antibody 6C8 (Fig. 9G).
While we cannot exclude an artifact of his-
tologic preparation, it is possible that bcl-2
also localizes to nuclei in certain cell types.
3F11 may recognize a different bcl-2
epitope than 4C11 or 6C8, that may be
presented on nuclear as well as cytoplasmic
bcl-2. It also remains possible that 3F11
recognizes an epitope on bcl-2 that is
conserved in other bcl-2-related proteins
(Bax or bcl-x) (Oltvai et al., 1993; Boise et
al., 1993). However, it should be noted that
the same cells that are identified as express-
ing bcl-2 with the monoclonal antibody
4C11 (Fig. 9F) and with the polyclonal
antibody B1 (Fig. 2F) are also detected
with 3F11; therefore any cross-reacting
protein would have to be regulated in a
pattern identical to bcl-2. In addition, in situ
hybridization of adult DRG neurons with a
full-length bcl-2 probe confirms the results
shown here. Lastly, LeBrun et al. (1993)
have shown bcl-2 protein in neurons of
spinal ganglia, as well as in spinal cord and
neocortex, confirming the results shown
here. It is also important to note the
expression of bcl-2 in the ‘supporting cells’
of the SCG and DRG, seen in Fig. 8A,B,
and Fig. 9G. These cells include members
of the macrophage/monocyte family which
represent peripheral nervous system
microglial equivalents (Vass et al., 1993).
Two-color immunofluorescence studies
of E18.5 dorsal root ganglia using 3F11 and
the embryonic neurofilament antibody 2H3
reveal an interesting finding. The smallest
neurons of the dorsal root ganglion, which
express the most intense levels of bcl-2, are
negative for 2H3 (Fig. 9B,D, arrow),
D. E. Merry and others
Fig. 7. bcl-2 expression in adult Rhesus monkey and human brain. (A) Staining of 18-year-
old Rhesus monkey frontal cortex with 6C8. (B) bcl-2 expression in monkey anterior
pituitary. (C,D) Two-color immunofluorescence of human frontal cortex with 6C8 (C) and
the CD45 antibody T29/33, which identifies microglia (D). Note the coincident staining
with the two antibodies. Representative cells are marked by arrows, but all anti-CD45-
positive cells are positive for bcl-2. (E-H) Two-color immunofluorescence of human
frontal cortex stained with 6C8 (E,G) and anti-NFH (F,H) antibodies. A rare neuron
concordant for the two antibodies is seen in G and H. Scale bar, 25 µm.
Fig. 8. bcl-2 expression in superior cervical ganglion (SCG). P20 (A) and 2.5 month (B)
mouse SCG stained with 3F11. Neurons as well as supporting cells are positive for bcl-2.
Filled arrows indicate representative neurons; open arrows indicate representative satellite
cells. Scale bar, 25 µm.
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whereas the larger neurons, which express bcl-2 at a lower
level or in a more diffuse pattern, are positive for the neuro-
filament antibody (Fig. 9B,D, arrowheads). This is consistent
with functional differences in these neurons (Carroll et al.,
1992; Ruit et al., 1992; Johnson et al.,
1980). 
Adrenal gland
Expression of bcl-2 in the adrenal
gland was observed in cells of both
the cortex and medulla (not shown).
Expression appears most intense in
cortical cells, and within the cortex is
highest in cells of the zona fascicu-
lata. The expression of bcl-2 in the
adrenal medulla and in other neurons
of neural crest origin is consistent
with the high level of bcl-2
expression seen in the vast majority
of neuroblastomas (Reed et al., 1991;
our unpublished observations). 
DISCUSSION
The findings from the present study
indicate that bcl-2 is more widely
expressed in neurons of the develop-
ing brain than in those of the adult.
High postnatal neuronal expression
of bcl-2 in the brain is confined to
those regions characterized by
postnatal neurogenesis and differen-
tiation (hippocampus, cerebellum,
olfactory bulb), as well as to the spe-
cialized neuroendocrine cells of the
anterior pituitary. However, bcl-2
expression in the peripheral nervous
system remains high throughout life.
The temporal and spatial patterns of
bcl-2 expression in the developing
central nervous system and in the
developing and adult peripheral
nervous system are consistent with a
role for bcl-2 in protecting neurons
from programmed cell death.
Two different populations of cells
in the developing nervous system
express bcl-2: proliferating stem cells
of ventricular zones and postmitotic
cells. bcl-2 is highly expressed in
very early ventricular zones (E10.5,
Fig. 1A) composed completely of
dividing cells, and in postmitotic dif-
ferentiating cells of many regions,
including the cortical plate, cerebel-
lar cortex and spinal cord. It may be
that this diverse and widespread
expression ensures the survival of an
excess of neurons, on which subse-
quent cell death mechanisms can act
to refine the number of differentiated, functional neurons to
match synaptic targets. 
The varied bcl-2 expression levels within dividing and post-
mitotic cells suggests a dynamic, regulated role for bcl-2; this
Fig. 9. Time course of bcl-2 expression in DRG. E18.5 (A), P20 (C), and 5 month (E,F) mouse
DRG stained with 3F11 (A,C,E) and 4C11 (F). The small, dark neurons appear to express higher
levels of bcl-2. Scale bar in A, 50 µm; scale bar for B-), 25 µm. (B,D) Two-color
immunofluorescence of E18.5 DRG with 3F11 (B) and 2H3 (D). Note that the larger 2H3-
positive neurons stain more weakly with 3F11 (arrowheads). This bcl-2 staining is above
background (control antibody not shown). The small, dark bcl-2-positive neurons are negative for
2H3 (arrow). (G) 16 year Rhesus monkey DRG stained with 6C8. Note that 6C8 also stains
satellite cells. Scale bar in G, 12.5 µm.
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is best exemplified by the two cortical regions studied here. In
the developing neocortex, the fate of neuronal precursors is
determined while they are still proliferating within the ven-
tricular zone (Bayer and Altman, 1991). It is intriguing that
even in early ventricular zones (E10.5), there were bcl-2-
negative cells in the mitotic zone that lines the ventricle (see
Fig. 1A). The intermediate zone is markedly negative for bcl-
2; however, whether this represents a change in bcl-2
expression within migrating cells or the more transient
character of cells within this region is unclear. As differen-
tiation proceeds in the neocortex, the differentiating cells of the
cortical plate express higher levels of bcl-2 than the stem cells
of the ventricular zone (Fig. 1C,D). The extent of neuronal
death within the developing cerebral cortex remains unclear.
The high expression of bcl-2 in this region, however, suggests
a need for the protective effects of bcl-2. Alternatively, the
expression of bcl-2 in the neocortex may indicate an additional
role for bcl-2 in a commitment/differentiation process. 
Within the developing cerebellum, as in the neocortex, bcl-
2 protein is highest in postmitotic differentiating cells, partic-
ularly granule cells. While bcl-2 is present in the proliferating
cells of the superficial EGL (termed EGLa by Kuhar et al.,
1993), the amount of bcl-2 protein increases in postmitotic
granule cell precursors of EGLb, which also express granule
cell-specific differentiation markers such as TAG-1 (Dodd et
al., 1988), astrotactin (Edmondson et al., 1988), and α-
internexin (Kaplan et al., 1990). bcl-2 remains high in granule
cells as they migrate through the developing molecular layer
and begin to extend their fibers (the parallel fibers), and is
retained in the fully differentiated cells of the internal granule
cell layer. As in the cortical layers of the forebrain, a signifi-
cant decrease in bcl-2 expression is noted in adult cerebellum,
indicating a change in the regulation of bcl-2 with aging. This
pattern of bcl-2 expression seen in developing cortical regions,
as well as in the differentiated neurons of the adult olfactory
epithelium, suggests that bcl-2 may play a role in the differ-
entiation of some neurons of the developing nervous system.
Alternatively, signals may exist in both dividing and differen-
tiating cell populations to express bcl-2 and repress a cell death
pathway. 
bcl-2 expression in many brain regions is maintained at a
high level throughout the period of cell death. As evidenced
by the bcl-2 immunostaining in the spinal cord from E13.5
through E18.5 (a period during which cell death of alpha
motoneurons takes place), there is no global decrease in bcl-2
expression in alpha motoneurons prior to the period of cell
death. Surviving alpha motoneurons express somewhat higher
levels of bcl-2 during this time than other spinal neurons; this
may relate to their survival, or to additional characteristics of
their differentiation. Other regions of the nervous system,
including cerebellar cortex, dorsal root ganglia and the devel-
oping retina (Veis et al., unpublished data), reveal bcl-2 protein
beyond the period when developmental cell death occurs. It
may be that for a particular neuron, the failure to encounter its
cognate neurotrophic factor(s) or receive adequate stimulation
results in a decrease in bcl-2, allowing that neuron to progress
along a death pathway. Alternatively, as mentioned, this
extended expression of bcl-2 may indicate an expanded role
for bcl-2 beyond protecting cells from death during develop-
ment. 
In contrast to the decline in bcl-2 expression seen in the brain
with aging, the neurons of the peripheral nervous system
(DRG, SCG and adrenal gland) continue to express high levels
of bcl-2 protein in the adult. The neurons of the peripheral
nervous system are capable of regeneration following injury
and, as in developing neurons, the survival of peripheral
neurons is dependent on target-derived neurotrophic factors.
The high level of bcl-2 protein that is maintained in adult
peripheral neurons is similar to its expression in developing
neurons and suggests a specific role for this survival factor in
both environments. In addition, the expression of bcl-2 in
mature peripheral neurons suggests a differential regulation of
bcl-2 protein compared with that found in neurons of the brain.
This may provide a potential approach to identifying factors
involved in the regulation of bcl-2 expression.
Within the aging brain, the decrease in bcl-2 protein is a
gradual one, with some neurons of the hippocampus, cerebel-
lum and cortex remaining positive well into postnatal life. This
tapering of bcl-2 may be due to the decay of long-lived protein.
Alternatively, it might also reflect a negative regulation of the
bcl-2 promoter with maturation as has been demonstrated in B
cell lines (Young and Korsmeyer, 1993). The decline of bcl-2
in CNS neurons might permit the neuronal loss seen in neu-
rodegenerative diseases. Alternatively, the decline in bcl-2 in
adult brain may be countered by expression of other bcl-2-like
gene(s) or by genes involved in other cell death pathways
(Allsopp et al., 1993). The established role of bcl-2 in protect-
ing neurons from cell death (Garcia et al., 1992; Allsopp et al.,
1993; Mah et al., 1993; Zhong et al., 1993; Batistatou et al.,
1993), combined with the patterns of bcl-2 expression in
neurons of the developing brain and adult peripheral nervous
system, support efforts to define regulators of bcl-2 expression
in an attempt to counter neurodegenerative cell loss. 
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